Gryphon Financial Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$230K Buy
2,660
+22
+0.8% +$2.11K 0.02% 329
2025
Q4
$253K Buy
+2,638
New +$256K 0.03% 301
2024
Q1
Sell
-2,672
Closed -$275K 265
2023
Q4
$275K Buy
+2,672
New +$204K 0.05% 197
2023
Q2
Sell
-2,939
Closed -$237K 214
2023
Q1
$237K Buy
+2,939
New +$240K 0.05% 178
2022
Q4
Sell
-3,037
Closed -$245K 207
2022
Q3
$245K Sell
3,037
-175
-5% -$15.7K 0.06% 164
2022
Q2
$289K Buy
3,212
+96
+3% +$9.73K 0.07% 149
2022
Q1
$346K Buy
3,116
+256
+9% +$27K 0.07% 144
2021
Q4
$296K Buy
2,860
+85
+3% +$9.84K 0.06% 169
2021
Q3
$348K Sell
2,775
-354
-11% -$45.8K 0.08% 134
2021
Q2
$354K Buy
3,129
+422
+16% +$53K 0.08% 132
2021
Q1
$320K Sell
2,707
-270
-9% -$31.6K 0.07% 133
2020
Q4
$349K Buy
2,977
+74
+3% +$8.15K 0.09% 113
2020
Q3
$302K Buy
+2,903
New +$292K 0.09% 119
2020
Q2
Sell
-2,740
Closed -$247K 152
2020
Q1
$247K Sell
2,740
-764
-22% -$81.3K 0.09% 122
2019
Q4
$398K Buy
3,504
+190
+6% +$20.8K 0.1% 112
2019
Q3
$360K Buy
3,314
+700
+27% +$73K 0.1% 110
2019
Q2
$254K Sell
2,614
-15,739
-86% -$1.44M 0.07% 125
2019
Q1
$1.67M Buy
18,353
+2,465
+16% +$221K 0.49% 24
2018
Q4
$1.45M Sell
15,888
-1,346
-8% -$126K 0.37% 51
2018
Q3
$1.7M Buy
17,234
+16,568
+2,488% +$1.53M 0.51% 25
2018
Q2
$57K Sell
666
-25
-4% -$2.09K 0.03% 206
2018
Q1
$56K Sell
691
-114
-14% -$9.4K 0.03% 206
2017
Q4
$65K Buy
+805
New +$64.5K 0.04% 201

Other funds holding MDT

Gryphon Financial Partners's MDT Position: Q1 2026 in Review

Gryphon Financial Partners increased its Medtronic (MDT) stake by 0.83% in Q1 2026, buying an estimated $2.11K and bringing the position to 2,660 shares worth $230K. The position accounts for 0.02% of the portfolio, ranked #329.

Gryphon Financial Partners first reported a position in MDT in Q4 2017 and has held it in 23 quarters since. The position peaked at $1.7M in Q3 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Gryphon Financial Partners held 2,660 shares of Medtronic worth $230K as of Q1 2026.
  • Gryphon Financial Partners bought 22 Medtronic shares in Q1 2026, an estimated $2.11K.
  • Medtronic made up 0.02% of Gryphon Financial Partners's portfolio in Q1 2026, its #329 holding.
  • Gryphon Financial Partners first reported a position in Medtronic in Q4 2017 and has held it in 23 quarters since.
  • Gryphon Financial Partners's Medtronic position peaked at $1.7M in Q3 2018.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Gryphon Financial Partners's 13F filing for Q1 2026, filed 6 May 2026.